dr. michael j. overman on immunotherapy in colorectal cancer
Published 7 years ago • 502 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:37
dr. overman on next steps with immunotherapy in mcrc
-
1:27
dr. overman on ongoing research with immunotherapy in mss crc
-
1:29
the role of immunotherapy in colorectal cancer
-
3:49
immunotherapy in colorectal cancer
-
1:09
dr. overman on second-line therapy options for colorectal cancer
-
1:38
dr. overman on remaining questions with immunotherapy in crc
-
1:22
dr. overman on potential applications of ctdna in colorectal cancer
-
1:18
dr. overman on unmet needs with immunotherapy in mcrc
-
23:16
my stage 4 colorectal cancer story: how i never lost hope | jason’s story | the patient story
-
7:22
immunotherapy trial for rectal cancer offers hope for future
-
4:41
actively living with colorectal cancer: stephen's immunotherapy story
-
3:17
immunotherapy in mss colorectal cancer
-
1:42
dr. overman on the impact of nivolumab in mcrc
-
1:15
dr. overman discusses progress with immunotherapy in gi cancer
-
2:15
dr. overman discusses redos study in mcrc
-
2:00
dr. overman on nivolumab and ipilimumab in patients with msi-h crc
-
1:03
dr. overman on implications of tumor location data for patients with mcrc
-
0:52
dr. larson on immunotherapy for colorectal cancer
-
5:49
immunotherapy and msi status in colorectal cancer
-
1:46
dr. overman on investigational targeted therapies in mcrc
-
1:29
dr. overman on tailoring approaches to molecular subsets in mcrc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc